Agent ide study.It was reported that stable angina occurred.On (b)(6) 2021, multiple synergy drug eluting stents implanted in left main (lm), left anterior descending artery (lad) and left circumflex artery (lcx).The proximal circumflex artery (cx) was treated with balloon angioplasty and synergy drug eluting stent (des).On (b)(6) 2022, the subject presented with stable angina and was referred for the agent ide study.The 90% stenosed target lesion was located at proximal cx and was 10 mm long with a reference vessel diameter of 3.5 mm.The target lesion was predilated using 4.0 mm x 20 mm nc balloon and laser atherectomy with 30% residual stenosis and timi flow of 3.Following pre-dilation, the lesion was treated with 3.50 mm x 30 mm study device successfully with 30% residual stenosis and timi flow of 3.The non-target lesion was located at left main coronary artery (lmca) and was treated using 5.0 mm x 12 mm balloon successfully prior to target lesion treatment.The subject was discharged on aspirin and clopidogrel.
|